@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_head { this: np:hasAssertion dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_assertion; np:hasProvenance dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_provenance; np:hasPublicationInfo dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_publicationInfo; a np:Nanopublication . dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_assertion a np:Assertion . dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_provenance a np:Provenance . dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_publicationInfo a np:PublicationInfo . } dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_assertion { miriam-gene:999 a ncit:C16612 . lld:C0685938 a ncit:C7057 . dgn-gda:DGN2d0a540bd00e6f1cdbc5ff15f263d33b sio:SIO_000628 miriam-gene:999, lld:C0685938; a sio:SIO_001121 . } dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_provenance { dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_assertion dcterms:description "[The results showed that; (i) genotypes with the +54C allele (C/C or C/T) significantly increased the risk of developing both ESCC and GCA compared to the +54T/T genotype (age and gender adjusted odds ratio [OR] = 1.45 and 2.28, 95% confidence interval [CI] = 1.06-1.99 and 1.58-3.30, respectively), and this association was significant only among non-smokers (OR = 1.68 and 2.64, 95% CI = 1.01-2.80 and 1.43-4.87 for ESCC and GCA, respectively), and individuals without a family history of upper gastrointestinal cancer (OR = 2.63 and 2.97, 95% CI = 1.36-5.10 and 95% CI = 1.32-6.68 for ESCC and GCA, respectively); (ii) compared with the -347G/G genotype, the -347GA and GA/GA genotypes significantly increased the risk of developing GCA (OR = 1.45, 95 % CI = 1.03-2.04); (iii) there was a significant association of CDH1-160C/-347G/+54C and -160C/-347GA/+54C haplotypes with the development of GCA, compared with the -160C/-347G/+54T haplotype (OR = 1.80 and 2.21, 95% CI = 1.33-2.44 and 1.43-3.42, respectively); and (iv) the influence of CDH1 SNP on the depth of tumor invasion and lymphatic metastasis in ESCC and GCA patients was not observed in this study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:18197935; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP186625.RApakedxJ18OxRqWCISw7U8suC0skWgoDXKP0oLuDwVZI130_publicationInfo { this: dcterms:created "2014-10-02T12:33:42+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }